{"uuid": "0307d523-9964-4e5d-bca7-829f74f1cf25", "state": {"code": "confirmed", "et": "Kinnitatud", "en": "confirmed"}, "last_update": "2025-02-10T02:09:02", "title": {"en": "Pharmacology and Toxicology", "et": "Farmakoloogia ja toksikoloogia"}, "credits": 4, "credit_type": "ECTS", "target": {"year": {"code": "2024", "et": "2024/2025", "en": "2024/2025"}, "semester": {"code": "spring", "et": "kevad", "en": "spring"}, "study_type": {"code": "fulltime", "et": "päevaõpe", "en": "regular studies"}, "language": {"code": "en", "et": "inglise keel", "en": "English"}, "part": {"code": "2", "et": "2. osa", "en": "part 2"}, "part_credits": 4, "faculty": {"code": "MV", "name": {"en": "Faculty of Medicine", "et": "meditsiiniteaduste valdkond"}, "address": "Tartu linn, \nTartu linn, Tartumaa \nEST", "city": "Tartu linn", "level": 1, "academic": true, "supports_continuous_learning": true}, "course_main_structural_unit": {"code": "MVBS02", "name": {"en": "Department of Pharmacology", "et": "farmakoloogia osakond"}, "phone": "+372 737 4350", "webpage_url": "https://biomeditsiin.ut.ee/et/sisu/farmakoloogia-osakond", "address": "EST", "level": 3, "academic": true, "supports_continuous_learning": false, "parent_code": "MVBS"}, "label": {"en": "24/25 S regular part 2 4 CP MV Eng", "et": "24/25 K PÕ 2. osa 4 EAP MV Eng"}}, "general": {"year": {"code": "2024", "et": "2024/2025", "en": "2024/2025"}, "input_languages": [{"code": "et", "et": "eesti keel", "en": "Estonian"}, {"code": "en", "et": "inglise keel", "en": "English"}], "structural_unit_shares": [{"structural_unit_code": "MVBS02", "structural_unit_name": {"en": "Department of Pharmacology", "et": "farmakoloogia osakond"}, "course_share_percent": 100, "coordinating": true}], "type": {"code": "regular", "et": "Tavaline aine", "en": "Regular course"}}, "additional_info": {"is_vota_course": true, "is_continuous_learning_course": false, "study_levels": [{"code": "bachelor_master", "et": "integreeritud bakalaureuse- ja magistriõpe", "en": "integrated bachelor's and master's studies"}], "hours": {"lecture": 13, "practice": 0, "seminar": 9, "independent_work": 82, "individual_work": 0, "internship": 0}, "prerequisites": [{"required": true, "uuid": "08062000-550e-51cc-0072-7fdd19958710", "code": "ARMB.01.020", "title": {"en": "Medical Microbiology", "et": "Meditsiiniline mikrobioloogia"}, "credits": 9, "state": {"code": "confirmed", "et": "Kinnitatud", "en": "confirmed"}, "last_update": "2024-02-05T11:04:36"}], "is_enlight_course": true}, "overview": {"study_languages": [{"code": "en", "et": "inglise keel", "en": "English"}], "description": {"en": "During this course, the goals of the course will be explained in the initial lecture. \n\nPharmacological terminology, types of receptors and drug specificity will be explained. \n\nPharmacodynamics, which is the action of the drug on the body, will be taught. Pharmacodynamics includes the action of the drug on the cell, the system and the body bearing in mind that the action of the drug will also be affected by its pharmacokinetic profile. \n\nPharmacokinetics, which is the action of the body on the drug, will be taught. Pharmacokinetics includes drug absorption, distribution, metabolism (biotransformation) and excretion (ADME). \n\nExemplar drugs will be used to teach the principles of pharmacokinetics and pharmacodynamics. \n\nPrinciples guiding therapeutic drug use and the side-effects of the main groups of drugs will be explained. \n\nDangerous side-effects of drugs, the general principles of cell damage and death, mutagenesis, carcinogenesis, teratogenicity and allergic reactions will be taught.", "et": "Kursuse käigus selgitatakse farmakoloogia ülesandeid ja põhimõisteid, retseptorite tüüpe ja ravimspetsiifilisust. Selgitatakse farmakokineetika põhilisi mehhanisme: ravimite imendumine, jaotumine, biotransformatsioon ja eritumine. Käsitletakse farmakokineetika mudeleid ja parameetreid. Selgitatakse farmakoloogilise vastusega ravimitele seotud mehhanisme, peamiste ravimirühmade farmakodünaamikat ja farmakokineetikat, kasutamisprintsiipe ja kõrvaltoimeid. Samuti käsitletakse ravimite ohtlikke kõrvaltoimeid, rakukahjustuse ja rakusurma üldisi printsiipe, mutageneesi, kartsinogeneesi, teratogeensust ja allergilisi reaktsioone."}, "objectives": [{"en": "The aim of the course is to provide basic knowledge on the main pharmacodynamic effects of drugs and groups of drugs. \n\nBy the end of the course, the student will know the primary pharmacodynamic effects of drugs and how drugs may be used in the treatment of diseases. \n\nThe student will become familiar with pharmacokinetic properties of drugs and drug groups and how the pharmacokinetic properties of drugs determines their efficacy and toxicity. \n\nStudents will become familiar with the side effects and potential toxicities of the main groups of drugs, the mechanisms of their side effects and principles to avoid these side effects. \n\nStudents will also become familiar with calculating doses and safe prescribing.", "et": "Kursuse eesmärgiks on anda üliõpilastele baasteadmised põhiliste ravimite või ravimrühmade farmakodünaamilistest toimetest. Üliõpilane teab kursuse lõpetamisel, kuidas ravimite primaarne farmakodünaamiline reaktsioon transformeerub sekundaarseks reaktsioonks ja kuidas seda kasutatakse haiguste ravis. Üliõpilane teab põhiliste ravimite farmakokineetilisi omadusi ja kuidas ravimi farmakokineetilised omadused määravad ravimite efektiivsuse ja toksilisuse. Üliõpilane teab põhiliste ravimite potentsiaalset toksilisust ja kõrvatoimeid, kõrvaltoimete mehhanisme ning nende vältimise printsiipe. Üliõpilane oskab ravimeid retseptis välja kirjutada vastavalt ravimiseadusele."}], "learning_outcomes": [{"en": "After passing the course student", "et": "Õppeaine läbinud õppija:"}, {"en": "Students who have passed this course in basic Pharmacology: \n\n-will understand the basic principles of pharmacokinetics and pharmacodynamics and will have built up a base of knowledge on the mechanisms of actions of the most-used drugs, at the molecular and whole-organism level. \n\n-will have learned about the most important groups of drugs and important representatives from each of these groups. For each of these representatives, the student will know the pharmacokinetic and pharmacodynamic properties, side-effects and the usefulness of the representative in treating particular conditions. \n\n-will have learned the mechanisms by which these representatives induce therapeutic effects and side effects and will have demonstrated knowledge on how to prevent or treat these side effects. \n\n-will have learned how to work with the scientific literature and will become capable of critically assessing published data in the field of pharmacology.", "et": "Kursuse läbinud üliõpilane teab farmakokineetika ja farmakodünaamika üldprintsiipe, tähtsamate ravimite toimeid ja toimemehhanisme nii molekulaarsel kui ka terve organismi tasandil. Üliõpilane teab ravimite põhirühmi ning rühmade tähtsamaid esindajaid. Üliõpilasel on iga ravimirühma esindaja kohta piisavalt teadmisi ravimi farmakokineetikast, farmakodünaamikast ja kõrvaltoimetest ning ta on võimeline põhjendama ravimi kasutamist teatud patoloogiliste seisundite korral. Üliõpilane teab, milliste mehhanismide kaudu ravimid avaldavad terapeutilist toimet ja kuidas ravimid võivad põhjustada kõrvaltoimeid ning oskab rakendada oma teadmisi kõrvaltoimete vältimiseks või korrigeerimiseks. Üliõpilane oskab töötada farmakoloogiaalase teadusliku kirjandusega ning on võimeline seda kriitiliselt analüüsima."}], "notes": {"et": "*******Groups are not permitted to switch their seminar session for any reason.\n\n*******Individual students are not permitted to switch their seminar session for any reason."}}, "grading": {"independent_work": {"et": "1) Students are required to complete some of the seminars in their own time, via Moodle resources. \n\nStudents achieving a high score in these E-learning modules will receive extra points in their next relevant Test. Students must pass this relevant Test on their initial attempt in order to benefit from these extra points. Please see Moodle for more details.\n\nAny student failing to attempt these seminars will be considered as having missed that seminar (see more below on missed seminars).\n\n2) Students are required to complete 1 oral presentation.  Students achieving a high score in this presentation will receive extra points in their next relevant Test. Students must pass this relevant Test on their initial attempt in order to benefit from these extra points. Please see Moodle for more details."}, "independent_work_assessments": [{"work_type": {"code": "test", "et": "Kontrolltöö", "en": "test"}, "description": {"et": "3 tests in Spring semester (Test 05-07), which are marked as follows.\n\nSitting 1:\nPoints (out of 25) 13.75\nPercentage 55%\n\nSitting 2:\nPoints (out of 25) 15\nPercentage 60%\n\nSitting 3:\nPoints (out of 25) 15\nPercentage 60% \n\n\nPlease see below for resits. Please see the Moodle site for this course for more details on each test.\n\nStudents can choose to miss the first sitting of any one Test (only one Test) and attend the second sitting of that Test without penalty and without an increase in threshold for passing.\n\nIf the student fails this attempt, they will of course have a final sitting (in fact, the third sitting in total) and a threshold of 60% will be applied.\n\nStudents failing the third and final resit of any Test shall be awarded \"F\" and then become immediately eligible for the Spring exam (see below).\n\nThe decision to miss the first sitting of any one Test will be the student's personal decision. The change to the rules is made to enable that personal decision. Doctors notes will not be required, prior emailed notification will not be required.\n\nPlease note:\nThis opportunity will be available for one Test. Should the student subsequently miss the first sitting of another Test, the normal rules will apply."}}, {"work_type": {"code": "written", "et": "Kirjalik lõpphindamine", "en": "final written assessment"}, "description": {"et": "Grade for Spring semester is calculated as the mean percentage score of Tests 05, 06, 07.\n"}}], "grade_preconditions": {"et": "The student has attended 7 lectures or more over the course of the spring semester. This INCLUDES online/virtual lectures. This INCLUDES lectures delivered as audio files - students failing to download the audio files on time will be regarded as non-attending.\n\nThe student has not missed more than two seminars over the course of the spring semester. \n\nThe student has passed all tests (Tests 05-07) with positive grade (see above for thresholds)."}, "grade_evaluation": {"et": "Mean percentage score for Tests 05-07\n\nGrade           Percentage (%)\nA                   91-100\nB                   81-90\nC                   71-80\nD                   61-70\nE                   55-60\nF                   54 or less"}, "debt_elimination": {"et": "Tests 5 - 7 may be sat up to 3 times.\n\nPlease see the Moodle web page for this course for the scheduling of resits.\n\n\nSpecial cases\n\n\nStudents who have failed all attempts of any of Tests 05-07 shall be awarded an \"F\" and will become immediately eligible for the Spring exam. \n\nStudents will then have two final opportunities to pass ARFR.03.047_ENG_Part II.\n\nOpportunity 1: Students will take \"Spring exam\", with contents covering materials from Tests 05 - 07.\nStudents failing to achieve threshold will be awarded a second \"F\".\nApproximate date: End of June \n\nOpportunity 2: Student will take \"Spring exam resit\", with contents covering materials from Tests 05 - 07.\nStudents failing to achieve threshold will be awarded a third and final \"F\" for the course.\nApproximate date: In the week preceding the new academic year.\n\n\nThreshold for passing the Spring exam\n\n28 points out of 50."}, "assessment_scale": {"code": "grade", "et": "Eristav (A, B, C, D, E, F, mi)", "en": "differentiated (A, B, C, D, E, F, not present)"}, "results_available_from": {"et": "Moodle and Ois"}}, "resources": {"web_based": {"code": "2", "et": "põimõpe", "en": "blended learning"}, "website_url": "http://moodle.ut.ee", "is_moodle_connected": true, "learning_environments": [{"uuid": "0098aaca-513f-42d1-8d53-4526cd401733", "type": "MOODLE", "code": "ARFR.02.037-EXAM_Part_2", "base_url": "undefined", "linked_to_groups": ["a0e3dc9a-be5f-07cb-f600-0b594c9fab94", "80fc3062-9506-44ab-18d9-ce65eb937969"], "is_auto_update": false, "is_default": false, "is_auto_grading": false}, {"uuid": "edb89e9b-677f-4f09-9829-e533836c6ebf", "type": "MOODLE", "code": "ARFR.02.037_ENG_part2", "base_url": "undefined", "is_auto_update": false, "is_default": true, "is_auto_grading": false}], "mandatory_materials": "Rang and Dale's Pharmacology, 9th edition Elsevier, Churchill Livingstone. Available from the University of Tartu library.", "recommended_materials": "Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th edition. The McGraw-Hill Companies, Inc. Available online from AccessMedicine:\nhttp://accessmedicine.mhmedical.com/book.aspx?bookid=374\n\nKatzung and Trevor Basic and Clinical Pharmacology, 14th edition, McGraw Hill Education.\nAvailable online from AccessMedicine:\nhttp://accessmedicine.mhmedical.com/book.aspx?bookId=388"}, "participants": {"lecturers": [{"person_uuid": "69a69077-7f6c-595a-2dbf-bb03fd86076c", "person_name": "Vinay Choubey", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "3", "et": "Seminarijuhendaja", "en": "supervisor of seminar"}, "1. rühm": {"code": "3", "et": "Seminarijuhendaja", "en": "supervisor of seminar"}}}, {"person_uuid": "1478452c-309b-8ad4-7982-d3ce02ee2bda", "person_name": "Miriam Ann Hickey", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": true, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}, "1. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}}}], "assistants": ["81c9b369-c85d-4855-01e1-78cf3c3cdc72"], "study_groups": [{"uuid": "a0e3dc9a-be5f-07cb-f600-0b594c9fab94", "code": "2. rühm", "max_size": 12}, {"uuid": "80fc3062-9506-44ab-18d9-ce65eb937969", "code": "1. rühm", "max_size": 12}]}, "schedule": {"weeks": {}, "entries": [{"course_week": 1, "time": "2024-02-12", "work_type": {"code": "e-learning", "et": "e-õpe", "en": "e-learning"}, "topic_number": 1, "topic": {}, "description": {"et": "Antipsychotics and anxiolytics (e-lecture)"}}, {"course_week": 1, "time": "2024-02-12", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic_number": 1, "topic": {}, "description": {"et": "Antipsychotics, anxiolytics"}}, {"course_week": 1, "time": "2024-02-19", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic_number": 1, "topic": {}, "description": {"et": "Anti-depressants and hypnotics"}}, {"course_week": 1, "time": "2024-02-19", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic_number": 1, "topic": {}, "description": {"et": "Anti-depressants and hypnotics"}}, {"course_week": 1, "time": "2024-02-26", "work_type": {"code": "e-learning", "et": "e-õpe", "en": "e-learning"}, "topic_number": 1, "topic": {}, "description": {"et": "Psychostimulants (e-lecture)"}}, {"course_week": 1, "time": "2024-02-26", "work_type": {"code": "practice", "et": "praktikum", "en": "practical session"}, "topic_number": 1, "topic": {}, "description": {"et": "Inter-professional education"}}, {"course_week": 1, "time": "2024-03-04", "work_type": {"code": "e-learning", "et": "e-õpe", "en": "e-learning"}, "topic_number": 1, "topic": {}, "description": {"et": "Treatment of epilepsy (e-lecture)"}}, {"course_week": 1, "time": "2024-03-04", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic_number": 1, "topic": {}, "description": {"et": "Treatment of neurodegenerative diseases (Parkinsonism, Alzheimer’s)."}}, {"course_week": 1, "time": "2024-03-04", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic_number": 1, "topic": {}, "description": {"et": "Treatment of neurodegenerative diseases (Parkinsonism, Alzheimer’s disease) and epilepsy."}}, {"course_week": 1, "time": "2024-03-11", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic_number": 1, "topic": {}, "description": {"et": "Local and general anaesthetics"}}, {"course_week": 1, "time": "2024-03-11", "work_type": {"code": "e-learning", "et": "e-õpe", "en": "e-learning"}, "topic_number": 1, "topic": {}, "description": {"et": "Local and general anaesthetics"}}, {"course_week": 1, "time": "2024-03-18", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic_number": 1, "topic": {}, "description": {"et": "Opioids and opioid antagonists. Drug addiction. Non-opioid analgesics"}}, {"course_week": 1, "time": "2024-03-18", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic_number": 1, "topic": {}, "description": {"et": "Opioids and opioid antagonists. Drug addiction. Non-opioid analgesics"}}, {"course_week": 1, "time": "2024-03-25", "work_type": {"code": "test", "et": "kontrolltöö", "en": "test"}, "topic_number": 1, "topic": {}, "description": {"et": "Psychopharmacology, analgesia and general anaesthesia"}}, {"course_week": 1, "time": "2024-04-01", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic_number": 1, "topic": {}, "description": {"et": "Anti-inflammatories Glucocorticoids. Agents affecting the immune system"}}, {"course_week": 1, "time": "2024-04-01", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic_number": 1, "topic": {}, "description": {"et": "Anti-inflammatories. Immune supressants and immune stimulants"}}, {"course_week": 1, "time": "2024-04-08", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic_number": 1, "topic": {}, "description": {"et": "Anti-cancer agents."}}, {"course_week": 1, "time": "2024-04-08", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic_number": 1, "topic": {}, "description": {"et": "Agents used in the treatment of anaemias. Anti-cancer agents"}}, {"course_week": 1, "time": "2024-04-15", "work_type": {"code": "test", "et": "kontrolltöö", "en": "test"}, "topic_number": 1, "topic": {}, "description": {"et": "Pharmacology of analgesics, anaesthetics, anti-inflammatories, agents affecting the immune system, blood and anti-cancer agents"}}, {"course_week": 1, "time": "2024-04-22", "work_type": {"code": "e-learning", "et": "e-õpe", "en": "e-learning"}, "topic_number": 1, "topic": {}, "description": {"et": "Folate synthesis inhibitors, gyrase inhibitors (e-lecture)"}}, {"course_week": 1, "time": "2024-04-22", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic_number": 1, "topic": {}, "description": {"et": "Antibacterial agents (cell wall inhibitors)"}}, {"course_week": 1, "time": "2024-04-29", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic_number": 1, "topic": {}, "description": {"et": "Antibacterial agents: Protein synthesis inhibitors"}}, {"course_week": 1, "time": "2024-04-29", "work_type": {"code": "e-learning", "et": "e-õpe", "en": "e-learning"}, "topic_number": 1, "topic": {}, "description": {"et": "E-learning Antibacterial agents: Folate synthesis inhibitors, gyrase inhibitors"}}, {"course_week": 1, "time": "2024-05-06", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic_number": 1, "topic": {}, "description": {"et": "Anti-viral agents, Anti-fungal agents"}}, {"course_week": 1, "time": "2024-05-06", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic_number": 1, "topic": {}, "description": {"et": "Antibacterial agents, anti-fungal and anti-viral agents"}}, {"course_week": 1, "time": "2024-05-13", "work_type": {"code": "test", "et": "kontrolltöö", "en": "test"}, "topic_number": 1, "topic": {}, "description": {"et": "Anti-bacterial, anti-fungal and anti-viral agents"}}]}, "registration_info": {"audience": {"et": "Arstiteadus 3"}, "min_students": 25, "max_students": 24}, "parent_uuid": "56695bbb-0317-d54f-209a-651a7ffeff47", "parent_code": "ARFR.02.037", "parent_credits": 9, "_actions": {"is_moodle_editable": false, "is_editable": false, "is_deletable": false}}